13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 56 holding rows worth $3,583,282,146.
- Accession
- 0001856083-25-000006
- Filer
- CIK 1856083
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 56 entries on the cover page, a total value of $3,583,282,146 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,583,282,146 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 4,154,086 | $259,547,293 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 3,808,144 | $249,128,780 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 4,300,000 | $236,328,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 4,000,978 | $189,966,435 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 8,000,382 | $181,048,645 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 3,000,000 | $178,290,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 9,728,845 | $156,828,981 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 15,726,349 | $156,162,646 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 11,932,137 | $139,486,682 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 9,356,171 | $137,535,714 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 4,215,811 | $118,042,708 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 5,380,449 | $116,110,089 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,715,691 | $113,973,353 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 900,000 | $109,305,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 3,000,000 | $108,060,000 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 3,948,910 | $102,395,236 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,800,000 | $65,394,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,200,000 | $62,328,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 41,096,522 | $56,302,235 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 7,495,000 | $56,287,450 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 6,057,024 | $55,966,902 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 3,150,000 | $55,125,000 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 1,000,000 | $54,710,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 3,352,804 | $52,940,775 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,000,000 | $51,740,000 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 2,654,781 | $51,051,438 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,200,000 | $48,180,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 7,859,648 | $45,035,783 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 450,000 | $41,220,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 2,426,657 | $38,316,914 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,470,172 | $33,972,984 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 300,000 | $28,728,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 483,092 | $28,198,080 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,000,000 | $25,300,000 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 2,279,892 | $19,675,468 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 751,422 | $19,379,173 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 1,250,000 | $17,875,000 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 1,500,000 | $17,685,000 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,239,353 | $15,294,781 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 481,267 | $14,760,459 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,454,562 | $12,218,321 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $7,187,871 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 878,516 | $7,159,905 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 549,439 | $6,444,919 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 1,000,000 | $5,890,000 | dollars as filed | |
| CORMEDIX INC COM | 21900C308 | Stock | 500,000 | $5,815,000 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 1,200,000 | $5,544,000 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 453,686 | $5,394,326 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 444,110 | $4,352,278 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 2,568,613 | $4,186,839 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 1,122,484 | $3,838,895 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 105,085 | $2,242,514 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 144,600 | $1,837,866 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 24,856 | $1,346,201 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 259,014 | $1,121,531 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 509,789 | $1,024,676 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-25-000006 | this filing | 2025-11-14 | acceptance time not in the bulk data set |